Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Aarthi Jayanthan, Paivi M. H. Miettunen, Andrea Incoronato, Clara L. Ortiz-Neira, Victor A. Lewis, Ronald Anderson, Dean E. C. Frohlich & Aru Narendran. (2010) CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PRESENTING WITH SEVERE OSTEOLYSIS: A Model to Study Leukemia-Bone Interactions and Potential Targeted Therapeutics. Pediatric Hematology and Oncology 27:3, pages 212-227.
Read now
Read now
G David Roodman. (2008) Novel targets for myeloma bone disease. Expert Opinion on Therapeutic Targets 12:11, pages 1377-1387.
Read now
Read now
Articles from other publishers (38)
Masahiro Hiasa, Takeshi Harada, Eiji Tanaka & Masahiro Abe. (2021) Pathogenesis and treatment of multiple myeloma bone disease. Japanese Dental Science Review 57, pages 164-173.
Crossref
Crossref
Rebecca E. Andrews, Janet E. Brown, Michelle A. Lawson & Andrew D. Chantry. (2021) Myeloma Bone Disease: The Osteoblast in the Spotlight. Journal of Clinical Medicine 10:17, pages 3973.
Crossref
Crossref
Shiva Kumar Reddy Mukkamalla & Dhatri Malipeddi. (2021) Myeloma Bone Disease: A Comprehensive Review. International Journal of Molecular Sciences 22:12, pages 6208.
Crossref
Crossref
Shuting Sun, Jianguo Tao, Parish P. Sedghizadeh, Philip Cherian, Adam F. Junka, Esmat Sodagar, Lianping Xing, Robert K. BoeckmanJrJr, Venkatesan Srinivasan, Zhenqiang Yao, Brendan F. Boyce, Brea Lipe, Jeffrey D. Neighbors, R. Graham G. Russell, Charles E. McKenna & Frank H. Ebetino. (2021) Bisphosphonates for delivering drugs to bone. British Journal of Pharmacology 178:9, pages 2008-2025.
Crossref
Crossref
Silvia Marino, Daniela N. Petrusca & G. David Roodman. (2020) Therapeutic targets in myeloma bone disease. British Journal of Pharmacology 178:9, pages 1907-1922.
Crossref
Crossref
Michael Heider, Katharina Nickel, Marion Högner & Florian Bassermann. (2021) Multiple Myeloma: Molecular Pathogenesis and Disease Evolution. Oncology Research and Treatment 44:12, pages 672-681.
Crossref
Crossref
Martina Chiu, Denise Toscani, Valentina Marchica, Giuseppe Taurino, Federica Costa, Massimiliano G. Bianchi, Roberta Andreoli, Valentina Franceschi, Paola Storti, Jessica Burroughs-Garcia, Rosa Alba Eufemiese, Benedetta Dalla Palma, Nicoletta Campanini, Eugenia Martella, Cristina Mancini, Jixiu Shan, Michael S. Kilberg, Giovanna D’Amico, Erica Dander, Luca Agnelli, Giancarlo Pruneri, Gaetano Donofrio, Ovidio Bussolati & Nicola Giuliani. (2020) Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability. Cancers 12:11, pages 3267.
Crossref
Crossref
Shivani Seth, Saurabh Zanwar, Linh Vu & Prashant Kapoor. (2020) Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects. Current Hematologic Malignancy Reports 15:2, pages 45-55.
Crossref
Crossref
Tarek H. Mouhieddine, Lachelle D. Weeks & Irene M. Ghobrial. (2019) Monoclonal gammopathy of undetermined significance. Blood 133:23, pages 2484-2494.
Crossref
Crossref
Valentina Marchica, Denise Toscani, Anna Corcione, Marina Bolzoni, Paola Storti, Rosanna Vescovini, Elisa Ferretti, Benedetta Dalla Accardi, Emanuela Vicario, Fabrizio Accardi, Cristina Mancini, Eugenia Martella, Domenico Ribatti, Angelo Vacca, Vito Pistoia & Nicola Giuliani. (2019) Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers 11:3, pages 321.
Crossref
Crossref
Fabrizio Accardi, Denise Toscani, Federica Costa, Franco Aversa & Nicola Giuliani. (2017) The Proteasome and Myeloma-Associated Bone Disease. Calcified Tissue International 102:2, pages 210-226.
Crossref
Crossref
Hailin Pang, Ningqiang Ma, Mi Jiao, Weiwei Shen, Bo Xin, Tongfei Wang, Feng Zhang, Lili Liu & Helong Zhang. (2017) The Biological Effects of Dickkopf1 on Small Cell Lung Cancer Cells and Bone Metastasis. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 25:1, pages 35-42.
Crossref
Crossref
B Dalla Palma, D Guasco, M Pedrazzoni, M Bolzoni, F Accardi, F Costa, G Sammarelli, L Craviotto, M De Filippo, L Ruffini, P Omedè, R Ria, F Aversa & N Giuliani. (2015) Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20. Leukemia 30:2, pages 409-416.
Crossref
Crossref
J Teramachi, R Silbermann, P Yang, W Zhao, K S Mohammad, J Guo, J L Anderson, D Zhou, R Feng, K-Z Myint, N Maertz, J H Beumer, J L Eiseman, J J Windle, X-Q Xie, G D Roodman & N Kurihara. (2015) Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo. Leukemia 30:2, pages 390-398.
Crossref
Crossref
P. J. J. Trojan, M. S. Bohatch-Junior, M. F. Otuki, F. Souza-Fonseca-Guimarães, P. V. Svidnicki, V. Nogaroto, D. Fernandes, E. A. Krum & G. M. Favero. (2016) Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line. Brazilian Journal of Biology 76:1, pages 59-65.
Crossref
Crossref
G David Roodman & Rebecca Silbermann. (2015) Mechanisms of osteolytic and osteoblastic skeletal lesions. BoneKEy Reports 4.
Crossref
Crossref
Wenzhuo Zhuang, Xueping Ge, Sijun Yang, Moli Huang, Wenyue Zhuang, Ping Chen, Xiaohui Zhang, Jinxiang Fu, Jing Qu & Bingzong Li. (2015) Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription. Stem Cells 33:6, pages 1985-1997.
Crossref
Crossref
Giada Bianchi & Nikhil C. Munshi. (2015) Pathogenesis beyond the cancer clone(s) in multiple myeloma. Blood 125:20, pages 3049-3058.
Crossref
Crossref
Fabrizio Accardi, Denise Toscani, Marina Bolzoni, Benedetta Dalla Palma, Franco Aversa & Nicola Giuliani. (2015) Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling. BioMed Research International 2015, pages 1-13.
Crossref
Crossref
Denise Toscani, Marina Bolzoni, Fabrizio Accardi, Franco Aversa & Nicola Giuliani. (2015) The osteoblastic niche in the context of multiple myeloma. Annals of the New York Academy of Sciences 1335:1, pages 45-62.
Crossref
Crossref
Antonio Garcia-Gomez. (2014) Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics. World Journal of Stem Cells 6:3, pages 322.
Crossref
Crossref
Abdul HameedJennifer J. BradyPaul DowlingMartin ClynesPeter O'Gorman. (2014) Bone Disease in Multiple Myeloma: Pathophysiology and Management. Cancer Growth and Metastasis 7, pages CGM.S16817.
Crossref
Crossref
Bhasker Koppula, Justin Kaptuch & Christopher J. Hanrahan. (2013) Imaging of Multiple Myeloma: Usefulness of MRI and PET/CT. Seminars in Ultrasound, CT and MRI 34:6, pages 566-577.
Crossref
Crossref
Tina W. Wong, Hirohito Kita, Curtis A. Hanson, Denise K. Walters, Bonnie K. Arendt & Diane F. Jelinek. (2013) Induction of Malignant Plasma Cell Proliferation by Eosinophils. PLoS ONE 8:7, pages e70554.
Crossref
Crossref
Rebecca Silbermann & G. David Roodman. (2013) Myeloma bone disease: Pathophysiology and management. Journal of Bone Oncology 2:2, pages 59-69.
Crossref
Crossref
M Bolzoni, G Donofrio, P Storti, D Guasco, D Toscani, M Lazzaretti, S Bonomini, L Agnelli, A Capocefalo, B Dalla Palma, A Neri, F Nicolini, G Lisignoli, F Russo, S Colla, F Aversa & N Giuliani. (2012) Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells. Leukemia 27:2, pages 451-463.
Crossref
Crossref
Knut Husmann, Matthias J.E. Arlt, Roman Muff, Bettina Langsam, Josefine Bertz, Walter Born & Bruno Fuchs. (2013) Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1832:2, pages 347-354.
Crossref
Crossref
Rebecca Silbermann & G. David Roodman. 2013. Osteoporosis. Osteoporosis
1465
1478
.
G. David Roodman. 2013. Genetic and Molecular Epidemiology of Multiple Myeloma. Genetic and Molecular Epidemiology of Multiple Myeloma
97
120
.
Anouk Caraux, Laure Vincent, Salahedine Bouhya, Philippe Quittet, Jérôme Moreaux, Guilhem Requirand, Jean-Luc Veyrune, Gaëlle Olivier, Guillaume Cartron, Jean-François Rossi & Bernard Klein. (2012) Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?. Oncotarget 3:11, pages 1335-1347.
Crossref
Crossref
Mitchell E. Menezes, Daniel J. Devine, Lalita A. Shevde & Rajeev S. Samant. (2011) Dickkopf1: A tumor suppressor or metastasis promoter?. International Journal of Cancer 130:7, pages 1477-1483.
Crossref
Crossref
Nicola Giuliani & Irma Airoldi. (2011) Novel Insights into the Role of Interleukin-27 and Interleukin-23 in Human Malignant and Normal Plasma Cells. Clinical Cancer Research 17:22, pages 6963-6970.
Crossref
Crossref
Alex R. Minter, Haley Simpson, Brendan M. Weiss & Ola Landgren. (2011) Bone Disease From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: Pathogenesis, Interventions, and Future Opportunities. Seminars in Hematology 48:1, pages 55-65.
Crossref
Crossref
Kimberly NoonanLuigi MarchionniJudy Anderson, Drew PardollG. David Roodman & Ivan Borrello. (2010) A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood 116:18, pages 3554-3563.
Crossref
Crossref
G. David Roodman. (2010) Targeting the bone microenvironment in multiple myeloma. Journal of Bone and Mineral Metabolism 28:3, pages 244-250.
Crossref
Crossref
Thomas L. Andersen, Kent Søe, Teis E. Sondergaard, Torben Plesner & Jean-Marie Delaisse. (2010) Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells. British Journal of Haematology 148:4, pages 551-561.
Crossref
Crossref
Katia Todoerti, Gina Lisignoli, Paola Storti, Luca Agnelli, Francesca Novara, Cristina Manferdini, Katia Codeluppi, Simona Colla, Monica Crugnola, Manuela Abeltino, Marina Bolzoni, Valentina Sgobba, Andrea Facchini, Giorgio Lambertenghi-Deliliers, Orsetta Zuffardi, Vittorio Rizzoli, Antonino Neri & Nicola Giuliani. (2010) Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease. Experimental Hematology 38:2, pages 141-153.
Crossref
Crossref
Joseph J. Pinzone, Brett M. HallNanda K. Thudi, Martin VonauYa-Wei Qiang, Thomas J. Rosol & John D. ShaughnessyJrJr. (2009) The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113:3, pages 517-525.
Crossref
Crossref